본문으로 건너뛰기
← 뒤로

Mendelian randomization analysis reveals no causal association between non-alcoholic fatty liver disease and hepatocellular carcinoma: implications for lipid metabolomics and shared pathophysiological mechanisms.

1/5 보강
Discover oncology 2025 Vol.16(1) p. 1765
Retraction 확인
출처

Wei Y, Li J

📝 환자 설명용 한 줄

[BACKGROUND] Non-alcoholic fatty liver disease (NAFLD) has been increasingly associated with hepatocellular carcinoma (HCC) risk in observational studies, yet the causal nature of this relationship an

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • p-value P = 0.088
  • 95% CI 0.993-0.999

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Wei Y, Li J (2025). Mendelian randomization analysis reveals no causal association between non-alcoholic fatty liver disease and hepatocellular carcinoma: implications for lipid metabolomics and shared pathophysiological mechanisms.. Discover oncology, 16(1), 1765. https://doi.org/10.1007/s12672-025-03582-0
MLA Wei Y, et al.. "Mendelian randomization analysis reveals no causal association between non-alcoholic fatty liver disease and hepatocellular carcinoma: implications for lipid metabolomics and shared pathophysiological mechanisms.." Discover oncology, vol. 16, no. 1, 2025, pp. 1765.
PMID 41021099

Abstract

[BACKGROUND] Non-alcoholic fatty liver disease (NAFLD) has been increasingly associated with hepatocellular carcinoma (HCC) risk in observational studies, yet the causal nature of this relationship and its impact on systemic lipid metabolism remains unclear. This study aimed to evaluate the bidirectional causal relationships between NAFLD and HCC, and their effects on lipid metabolomics profiles using Mendelian randomization.

[METHODS] We conducted comprehensive Mendelian randomization analyses using genetic variants as instrumental variables. For NAFLD exposure analysis, 6 single nucleotide polymorphisms (SNPs) were selected, while 55 SNPs were used for HCC exposure in reverse analysis. Four statistical methods were employed: inverse variance weighted (IVW), MR Egger regression, weighted mode, and simple mode. The study evaluated causal effects on over 30 metabolic biomarkers, including triacylglycerols, phosphatidylcholines, phosphatidylinositols, ceramides, and sphingolipids. Comprehensive sensitivity analyses were performed to assess horizontal pleiotropy and result robustness.

[RESULTS] No statistically significant causal association was found between NAFLD and HCC risk across all four methods (MR Egger: OR 0.996, 95% CI 0.993-0.999, P = 0.088; IVW: OR 1.000, 95% CI 0.999-1.001, P = 0.969; weighted mode: OR 0.999, 95% CI 0.998-1.001, P = 0.447; simple mode: OR 1.001, 95% CI 0.999-1.002, P = 0.402). Reverse Mendelian randomization showed no significant causal effect of HCC on NAFLD development. Both NAFLD and HCC demonstrated limited direct causal effects on lipid metabolomics profiles, with confidence intervals for most metabolites clustering tightly around the null value (0.990-1.010). Only a few phospholipid compounds showed marginal significance in NAFLD analysis. Sensitivity analyses confirmed result robustness without evidence of horizontal pleiotropy.

[CONCLUSIONS] This comprehensive Mendelian randomization study challenges the assumption of direct causal relationships between NAFLD, HCC, and systemic lipid metabolism.

같은 제1저자의 인용 많은 논문 (5)